Table 7.
Rifaximin and lactulose administration by analysis group 48–72 h post-intubation
| Altered Mental Status/HE | Respiratory Failure/Cardiovascular Instability | Procedure | All Patients | |
|---|---|---|---|---|
|
| ||||
| n | 70 | 150 | 94 | 314 |
| 24-h prior to intubation | ||||
| Patients given Rifaximin (%) | 41 (58.6) | 62 (41.3) | 31 (33.0) | 134 (42.7) |
| Lactulose enema received (%) | 3 (4.3) | 5 (3.3) | 7 (7.4) | 15 (4.8) |
| Patients given Lactulose PO1 (%) | 46 (65.7) | 84 (56.0) | 61 (64.9) | 191 (60.8) |
| Lactulose PO1 median number of doses2,3 [IQR] | 6 [4, 10] | 6 [3, 8] | 4 [2, 6] | 6 [2.5,8] |
1
Oral administration
2
Calculated based only on patients that received the treatment
3
1 dose Lactulose: 10 g